Zhang Jingjing, Liu Fang, Zheng Kunkun, Wan Lei
Eye Institute of Shandong First Medical University, Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Jinan 250021, China.
State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Qingdao 266071, China.
J Ophthalmol. 2025 Mar 19;2025:6846620. doi: 10.1155/joph/6846620. eCollection 2025.
To evaluate a modified minimally invasive technique for trans-scleral repositioning of dislocated Akreos Adapt intraocular lenses (IOLs) without scleral flaps. This retrospective case series included 17 eyes with subluxated or dislocated IOLs that underwent repositioning using a suture-in-needle, closed-loop technique. The procedure involved passing an 8-0 polypropylene suture through the IOL's four fenestrated haptics using a bent 30-gauge needle. The exterior suture knot was buried into the sclera without creating scleral flaps or dissecting the conjunctiva. Data on pre- and postoperative intraocular pressure, best-corrected visual acuity, IOL position, corneal endothelial cell counts, and intra-/postoperative complications were collected and analyzed. The follow-up period lasted at least 6 months. All 17 cases demonstrated stable and well-centered IOLs with improved visual acuity. No significant complications, including IOL tilt, decentration, vitreous hemorrhage, hypotony, iris capture, or suture erosion, were observed during the follow-up. The suture-in-needle, closed-loop technique for trans-scleral refixation of dislocated Akreos Adapt IOLs is minimally invasive, achieves excellent anatomical and functional outcomes, and reduces the risk of complications.
评估一种改良的微创技术，用于在不制作巩膜瓣的情况下对脱位于巩膜的Akreos Adapt人工晶状体（IOL）进行经巩膜复位。这项回顾性病例系列研究纳入了17例人工晶状体半脱位或脱位的患眼，这些患眼采用缝针闭环技术进行了复位。该手术过程包括使用一根弯曲的30号针将一根8-0聚丙烯缝线穿过人工晶状体的四个有孔襻。将外部缝线结埋入巩膜，不制作巩膜瓣或分离结膜。收集并分析术前和术后的眼压、最佳矫正视力、人工晶状体位置、角膜内皮细胞计数以及术中/术后并发症的数据。随访期至少持续6个月。所有17例患者的人工晶状体均稳定且居中良好，视力得到改善。随访期间未观察到明显并发症，包括人工晶状体倾斜、偏心、玻璃体积血、低眼压、虹膜夹持或缝线侵蚀。缝针闭环技术用于脱位于巩膜的Akreos Adapt人工晶状体的经巩膜重新固定，具有微创性，可实现出色的解剖和功能结果，并降低并发症风险。
